Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer

Breast Cancer Research and Treatment

Volumn 41, Issue 1, 1996, Pages 81-89

  Chevillard, S ^a   Muller A ^a   Levalois, C ^a   Laine Bidron C ^a   Vielh, Ph ^a   Magdelenat H ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Estrogen receptor; Polymerase chain reaction; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE;

EID: 0029851663     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01807039     Document Type: Article

References (17)

1. Osborne CK, Yochmowitz MG, Knight WA III, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888, 1980
2. Wenger CR, Beardslee S, Owens MA, Pouds G, Oldaker T, Vendely P, Pandian MR, Harrington D, Clark GM, McGuire WL: DNA ploidy, S-phase, and steroid receptors in more than 127000 breast cancer patients. Breast Cancer Res Treat 28: 9-20, 1993
3. Foekens JA, Peters HA, Portengen H, Noordegraaf E, Berns EM, Klijn JGM: Cell biological prognostic factors in breast cancer: a review. J Clin Immunoassay 14: 184-195, 1991
4. Dali P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaulmann M, Heerlich P, Ponta H: Comparison of immunohistochcmistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477, 1995
5. Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H, Graeff H: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208, 1993
6. Chevillard S, Pouillart P, Beldjord C, Asselain B, Beuzeboc P, Magdelénat H, Vielh P: Sequential assessment of multi-drug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 77: 292-300, 1996
7. Dutrillaux B, Gerbault-Sereau M, Remvikos Y, Zafrani B, Prieur M: Breast cancer genetic evolution: I. Data from cytogenetics and DNA content. Breast Cancer Res Treat 19: 245-255, 1991
8. Blankenstein MA: Comparison of ligand binding assay and enzymoimmunoassay of estrogen receptor in human breast cancer cytosols. Experience of the EORTC Receptor Study Group. Breast Cancer Res Treat 17: 91-98, 1990
9. Fiszer-Szafarz B, Szafarz D, Guevara de Murilla A: A general, fast and sensitive micromethod for DNA determination. Anal Biochem 110: 165-170, 1981
10. Ponglikitmonkol M, Green S, Chamhon P: Genomic organization of the human estrogen receptor gene. EMBO J 7: 3385-3388, 1988
11. Misrahi M, Venencie PY, Saugier-Veber P, Sar S, Dessen P, Milgrom E: Structure of the human progesterone receptor gene. Biochem Biophys Acta 1216: 289-292, 1993
12. Romain S, Lainé Bidron C, Martin PM, Magdelénat H on behalf of the EORTC Receptor Study Group: Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 31A: 411-417, 1995
13. McGuire WL: Breast cancer prognostic factors: Evaluation guidelines. J Natl Cancer Inst 83: 154-155, 1991
14. McGuire WL, De la Garza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res .37: 637-639, 1977
15. May E, Mouriesse H, May-Levin F, Contesso G, Delarue JC: A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. Oncogene 4: 1037-1042, 1989
16. Fuqua SAW, Falette NF, McGuire WL: Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst 82: 858-860, 1990
17. Nagai MA, Marques LA, Yamamoto L, Fujiyama CT, Brentani MM: Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features. Int J Cancer 59: 351-356, 1994